Exchange: NASDAQ·Updated 09:35 AM EDT
ALLO logo

ALLO Allogene Therapeutics Inc

$1.70
$0.01
(0.59%)
Today
EarningsNov 5
Mkt Cap$583.88M
Vol14,184.00

About ALLO

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.
39

Bearish Sentiment

How do you feel about ALLO?

Daryl142
$ALLO oh my. I’ve been holding ALLO for nearly 10 years hoping and praying that this is the cure to end all. Now, I just want them to get bought out already!
10
rlkloehn
$ALLO (1178) Preliminary Safety and Efficacy Results From a First-in-Human Phase 1 Clinical Study of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogeneic CAR T-Cell Therapy for Autoimmune Disease Monday, November 9, 2026 10:30 AM - 12:30 PM East Coast USA Time
8
DoctrBenway
$ALLO I don't think Arie would be here if there wasn't extreme promise. I doubled down today @ 2.07, will triple @ 1.99 should it trip.
6
HughGeez
$ALLO I just entered. I think at some point this thing will bounce back. Whether that's this week or next year, I wish I knew. In for the long haul.
5
x_pressionist
$ALLO Short interest 118 mn as of August 31, 2026. We just need one piece of good news to send this thing not to the Moon, but straight to Mars!
4
StijnRR
$ALLO — More new Allogene job postings have appeared in recent days, with several focused on manufacturing, process development, analytical science and supply chain. What stands out is that the company is still hiring for PPQ, BLA readiness and commercial pre/post-launch activities, not just early-stage R&D. This suggests management continues to invest heavily in the infrastructure needed to bring its pipeline toward commercialization, which I see as a bullish signal for ALLO-329 and ALPHA3. Of course, jobs don’t guarantee positive data, but continuing to build this organization ahead of major catalysts is certainly encouraging.
4
JHisai
$ALLO upper trendchannel line in weekly logchart at 1.72, also have a bookmark at 1.64, which would suck ...
1
Unburdened
$ALLO Need to stop watching this stock every day. We know nothing's gonna happen until next year. They seem to be moving ahead with expansion of jobs with a thought of good results next year. In the meantime, we continue to have new shareholders at our expense because of incompetent management and the debacle that was the equity raise.
2
Edadi
$ALLO the careers openings seem as a positive sign, if we start to see a steady slow climb, might be getting ready for significant release in the ASH congress in December (the most important congress in hematology)
2
AS1980
$ALLO how many fckn red days during the last fckn month ? Piece of shit Damn the fckrs raised at 2s and did not wait after the announcement Cannot forget this shit
kafksdsdvsdl
$ALLO my buy order at 1.77 did not go though for a whole hour. Just got in at 1.78. Seems pretty firm base at least for today.
x_pressionist
$ALLO I don’t believe ALLO has had six consecutive red days in the past year. Could today be the first time?

Advertisement|Remove ads.